Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 β2-glycoprotein I variant

Shinsuke Yasuda, Tatsuya Atsumi, Eiji Matsuura, Keiko Kaihara, Daisuke Yamamoto, Kenji Ichikawa, Takao Koike

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Objective. To clarify the consequences of the valine/leucine polymorphism at position 247 of the β2-glycoproiein I (β2GPI) gene in patients with antiphospholipid syndrome (APS), by investigating the correlation between genotypes and the presence of anti-β2GPI antibody. The reactivity of anti-β2GPI antibodies was characterized using recombinant Val247 and Leu247 β2GPI. Methods. Sixty-five Japanese patients with APS and/or systemic lupus erythematosus who were positive for antiphospholipid antibodies and 61 controls were analyzed for the presence of the Val/Leu247 polymorphism of β2GPI. Polymorphism assignment was determined by polymerase chain reaction followed by restriction enzyme digestion. Recombinant Val247 and Leu247 β2GPI were established to compare the reactivity of anti-β2GPI antibodies to β2GPI between these variants. The variants were prepared on polyoxygenated plates or cardiolipin-coated plates, and the reactivity of a series of anti-β2GPI antibodies (immunized anti-human β2GPI monoclonal antibodies [Cof-19-21] and autoimmune anti-β2GPI monoclonal antibodies [EY1C8, EY2C9, and TM1G2]) and IgGs purified from patient sera was investigated. Results. A positive correlation between the Val247 allele and the presence of anti-β2GPI antibodies was observed in the patient group. Human monoclonal/ polyclonal anti-β2GPI autoantibodies showed higher binding to recombinant Val247 β2GPI than to Leu 247 β2GPI, although no difference in the reactivity of the immunized anti-β2GPI between these variants was observed. Conformational optimization showed that the replacement of Leu247 by Val247 led to a significant alteration in the tertiary structure of domain V and/or the domain IV-V interaction. Conclusion. The Val247 β2GPI allele was associated with both a high frequency of anti-β2GPI antibodies and stronger reactivity with anti-β2GPI antibodies compared with the Leu247 β2GPI allele, suggesting that the Val247 β2GPI allele may be one of the genetic risk factors for development of APS.

Original languageEnglish
Pages (from-to)212-218
Number of pages7
JournalArthritis and Rheumatism
Volume52
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Antiphospholipid Syndrome
Valine
Autoantibodies
Glycoproteins
Antibodies
Alleles
Monoclonal Antibodies
Antiphospholipid Antibodies
Cardiolipins
Leucine
Systemic Lupus Erythematosus
Digestion
Anti-Idiotypic Antibodies
Genotype
Polymerase Chain Reaction
Enzymes
Serum
Genes

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome : Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 β2-glycoprotein I variant. / Yasuda, Shinsuke; Atsumi, Tatsuya; Matsuura, Eiji; Kaihara, Keiko; Yamamoto, Daisuke; Ichikawa, Kenji; Koike, Takao.

In: Arthritis and Rheumatism, Vol. 52, No. 1, 01.2005, p. 212-218.

Research output: Contribution to journalArticle

@article{d2ec12d6f1cd49c681a891c2e0c8e3ad,
title = "Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 β2-glycoprotein I variant",
abstract = "Objective. To clarify the consequences of the valine/leucine polymorphism at position 247 of the β2-glycoproiein I (β2GPI) gene in patients with antiphospholipid syndrome (APS), by investigating the correlation between genotypes and the presence of anti-β2GPI antibody. The reactivity of anti-β2GPI antibodies was characterized using recombinant Val247 and Leu247 β2GPI. Methods. Sixty-five Japanese patients with APS and/or systemic lupus erythematosus who were positive for antiphospholipid antibodies and 61 controls were analyzed for the presence of the Val/Leu247 polymorphism of β2GPI. Polymorphism assignment was determined by polymerase chain reaction followed by restriction enzyme digestion. Recombinant Val247 and Leu247 β2GPI were established to compare the reactivity of anti-β2GPI antibodies to β2GPI between these variants. The variants were prepared on polyoxygenated plates or cardiolipin-coated plates, and the reactivity of a series of anti-β2GPI antibodies (immunized anti-human β2GPI monoclonal antibodies [Cof-19-21] and autoimmune anti-β2GPI monoclonal antibodies [EY1C8, EY2C9, and TM1G2]) and IgGs purified from patient sera was investigated. Results. A positive correlation between the Val247 allele and the presence of anti-β2GPI antibodies was observed in the patient group. Human monoclonal/ polyclonal anti-β2GPI autoantibodies showed higher binding to recombinant Val247 β2GPI than to Leu 247 β2GPI, although no difference in the reactivity of the immunized anti-β2GPI between these variants was observed. Conformational optimization showed that the replacement of Leu247 by Val247 led to a significant alteration in the tertiary structure of domain V and/or the domain IV-V interaction. Conclusion. The Val247 β2GPI allele was associated with both a high frequency of anti-β2GPI antibodies and stronger reactivity with anti-β2GPI antibodies compared with the Leu247 β2GPI allele, suggesting that the Val247 β2GPI allele may be one of the genetic risk factors for development of APS.",
author = "Shinsuke Yasuda and Tatsuya Atsumi and Eiji Matsuura and Keiko Kaihara and Daisuke Yamamoto and Kenji Ichikawa and Takao Koike",
year = "2005",
month = "1",
doi = "10.1002/art.20741",
language = "English",
volume = "52",
pages = "212--218",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome

T2 - Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 β2-glycoprotein I variant

AU - Yasuda, Shinsuke

AU - Atsumi, Tatsuya

AU - Matsuura, Eiji

AU - Kaihara, Keiko

AU - Yamamoto, Daisuke

AU - Ichikawa, Kenji

AU - Koike, Takao

PY - 2005/1

Y1 - 2005/1

N2 - Objective. To clarify the consequences of the valine/leucine polymorphism at position 247 of the β2-glycoproiein I (β2GPI) gene in patients with antiphospholipid syndrome (APS), by investigating the correlation between genotypes and the presence of anti-β2GPI antibody. The reactivity of anti-β2GPI antibodies was characterized using recombinant Val247 and Leu247 β2GPI. Methods. Sixty-five Japanese patients with APS and/or systemic lupus erythematosus who were positive for antiphospholipid antibodies and 61 controls were analyzed for the presence of the Val/Leu247 polymorphism of β2GPI. Polymorphism assignment was determined by polymerase chain reaction followed by restriction enzyme digestion. Recombinant Val247 and Leu247 β2GPI were established to compare the reactivity of anti-β2GPI antibodies to β2GPI between these variants. The variants were prepared on polyoxygenated plates or cardiolipin-coated plates, and the reactivity of a series of anti-β2GPI antibodies (immunized anti-human β2GPI monoclonal antibodies [Cof-19-21] and autoimmune anti-β2GPI monoclonal antibodies [EY1C8, EY2C9, and TM1G2]) and IgGs purified from patient sera was investigated. Results. A positive correlation between the Val247 allele and the presence of anti-β2GPI antibodies was observed in the patient group. Human monoclonal/ polyclonal anti-β2GPI autoantibodies showed higher binding to recombinant Val247 β2GPI than to Leu 247 β2GPI, although no difference in the reactivity of the immunized anti-β2GPI between these variants was observed. Conformational optimization showed that the replacement of Leu247 by Val247 led to a significant alteration in the tertiary structure of domain V and/or the domain IV-V interaction. Conclusion. The Val247 β2GPI allele was associated with both a high frequency of anti-β2GPI antibodies and stronger reactivity with anti-β2GPI antibodies compared with the Leu247 β2GPI allele, suggesting that the Val247 β2GPI allele may be one of the genetic risk factors for development of APS.

AB - Objective. To clarify the consequences of the valine/leucine polymorphism at position 247 of the β2-glycoproiein I (β2GPI) gene in patients with antiphospholipid syndrome (APS), by investigating the correlation between genotypes and the presence of anti-β2GPI antibody. The reactivity of anti-β2GPI antibodies was characterized using recombinant Val247 and Leu247 β2GPI. Methods. Sixty-five Japanese patients with APS and/or systemic lupus erythematosus who were positive for antiphospholipid antibodies and 61 controls were analyzed for the presence of the Val/Leu247 polymorphism of β2GPI. Polymorphism assignment was determined by polymerase chain reaction followed by restriction enzyme digestion. Recombinant Val247 and Leu247 β2GPI were established to compare the reactivity of anti-β2GPI antibodies to β2GPI between these variants. The variants were prepared on polyoxygenated plates or cardiolipin-coated plates, and the reactivity of a series of anti-β2GPI antibodies (immunized anti-human β2GPI monoclonal antibodies [Cof-19-21] and autoimmune anti-β2GPI monoclonal antibodies [EY1C8, EY2C9, and TM1G2]) and IgGs purified from patient sera was investigated. Results. A positive correlation between the Val247 allele and the presence of anti-β2GPI antibodies was observed in the patient group. Human monoclonal/ polyclonal anti-β2GPI autoantibodies showed higher binding to recombinant Val247 β2GPI than to Leu 247 β2GPI, although no difference in the reactivity of the immunized anti-β2GPI between these variants was observed. Conformational optimization showed that the replacement of Leu247 by Val247 led to a significant alteration in the tertiary structure of domain V and/or the domain IV-V interaction. Conclusion. The Val247 β2GPI allele was associated with both a high frequency of anti-β2GPI antibodies and stronger reactivity with anti-β2GPI antibodies compared with the Leu247 β2GPI allele, suggesting that the Val247 β2GPI allele may be one of the genetic risk factors for development of APS.

UR - http://www.scopus.com/inward/record.url?scp=12344312949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344312949&partnerID=8YFLogxK

U2 - 10.1002/art.20741

DO - 10.1002/art.20741

M3 - Article

C2 - 15641049

AN - SCOPUS:12344312949

VL - 52

SP - 212

EP - 218

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 1

ER -